ENTO insider filings
Entero Therapeutics, Inc. — 5 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-01-08. Screen ENTO transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ENTO between 2026-07-26 and 2026-10-24. The table below lists the most recent filings on record.
Recent insider filings — Entero Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-08 | 4 | Romano Sarah — Chief Financial Officer | Sale (S): 727 @ $0.64 | EDGAR |
| 2024-10-10 | 4 | Romano Sarah — Chief Financial Officer | Sale (S): 476 @ $0.45 | EDGAR |
| 2024-07-03 | 4 | Romano Sarah — Chief Financial Officer | Sale (S): 621 @ $1.07 | EDGAR |
| 2024-07-03 | 4 | SAPIRSTEIN JAMES — Chairman and CEO, Director | Sale (S): 1,289 @ $1.07 | EDGAR |
| 2024-06-12 | 4 | KHOSLA CHAITAN PHD — Director | Grant/award (A): 24,889 @ $0 | EDGAR |
Recent 8-K events — Entero Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-10-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-07-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-28 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Entero Therapeutics, Inc.
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-296288 (S-1) — latest: Amendment (S-1/A), filed 2026-10-06
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ENTO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs